title: Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. European Randomized Multicenter Trial.
authors.affiliation: University Children's Hospital, Free University, Department of Neonatology, Berlin, FRG.
authors.forename: M
authors.initials: M
authors.lastname: Obladen
authors.forename: R
authors.initials: R
authors.lastname: Maier
authors.forename: H
authors.initials: H
authors.lastname: Segerer
authors.forename: E L
authors.initials: EL
authors.lastname: Grauel
authors.forename: B M
authors.initials: BM
authors.lastname: Holland
authors.forename: G
authors.initials: G
authors.lastname: Stewart
authors.forename: G
authors.initials: G
authors.lastname: Jorch
authors.forename: H
authors.initials: H
authors.lastname: Rabe
authors.forename: O
authors.initials: O
authors.lastname: Linderkamp
authors.forename: H G
authors.initials: HG
authors.lastname: Hoffmann
mesh_terms: D000740:Anemia / Q000517:prevention & control*; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin